Doxazosin in physiologically and pharmacologically normotensive men with benign prostatic hyperplasia

By Kaplan S.A.   Meade-D'Alisera P.   Quinones S.   Soldo K.A.  

Urology, Vol. 46, Iss. 4, 1995-10 ,pp. : 512-517

Elsevier

Access to resources Recommend Favorite

Effects of terazosin therapy on blood pressure in men with benign prostatic hyperplasia concurrently treated with other antihypertensive medications

By Lowe F.C.   Olson P.J.   Padley R.J.  

Urology, Vol. 54, Iss. 1, 1999-07 ,pp. : 81-85

Elsevier

Access to resources Recommend Favorite

Effects of sildenafil citrate (viagra) on blood pressure in normotensive and hypertensive men

By Vardi Y.   Klein L.   Nassar S.   Sprecher E.   Gruenwald I.  

Urology, Vol. 59, Iss. 5, 2002-05 ,pp. : 747-752

Elsevier

Access to resources Recommend Favorite

Discontinuation of alpha-blockade after initial treatment with finasteride and doxazosin in men with lower urinary tract symptoms and clinical evidence of benign prostatic hyperplasia

By Baldwin K.C.   Ginsberg P.C.   Roehrborn C.G.   Harkaway R.C.  

Urology, Vol. 58, Iss. 2, 2001-08 ,pp. : 203-208

Elsevier

Access to resources Recommend Favorite

Clinical correlation of maximal urinary flow rate and plasma doxazosin concentrations in the treatment of benign prostatic hyperplasia - early onset of action and efficacy of lower dose therapy

By Fawzy A.   Vashi V.   Chung M.   Dias N.   Gaffney M.  

Urology, Vol. 53, Iss. 2, 1999-02 ,pp. : 329-335

Elsevier

Access to resources Recommend Favorite